PUBLIC COMPANY
save$ANVSAnnovis Bio, Inc.
$ANVSMalvern, PA, USupdated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3An Open-label Long-term Safety Study of Buntanetap in Participants With AD
- phase3A Double-blind Dual Study Assessing Safety and Efficacy of Buntanetap in Participants With Early AD
- phase3A Study of Buntanetap in Participants With PD
- phase3A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate AD
- phase3A Double-blind Study to Investigate Efficacy and Safety of Buntanetap Compared With Placebo in Participants With Early PD
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 2, 26BUYHoffman Michael B· $1.50M↗
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 27m ago
Found something off?
comments(0)
5-min edit window · permanent after that